
Janet Freilich
Professor of Law
Class of 1960 Scholar
BA, Cornell University
JD, Harvard Law School
Postdoctoral Fellowship, Harvard Law School
Biography
Professor Janet Freilich writes and teaches in the areas of patent law, intellectual property, information law, and civil procedure. She has published or has articles forthcoming in peer reviewed journals including Science, The New England Journal of Medicine, The Lancet, JAMA, and the Review of Statistics and Economics and law reviews including the University of Pennsylvania Law Review, the Virginia Law Review, and others. Freilich was previously a professor at Fordham Law School where she received the Fordham Law Dean’s Distinguished Research Award. She has also received the Samsung-Stanford Patent Prize, the Irving Oberman Memorial Award in Intellectual Property, and the Cloud Based Research Computing Project Award.
Professor Freilich has spent time as a visiting scholar at Massachusetts Institute of Technology’s Sloan School of Management; Harvard Medical School’s Program on Regulation, Therapeutics, and Law; and at Boston University School of Law. She was Harvard Law School’s inaugural postdoctoral fellow in private law and intellectual property with the Program on the Foundations of Private Law. Prior to joining the academy, Freilich practiced law at Covington & Burling LLP. She graduated magna cum laude from Harvard Law School and summa cum laude from Cornell University with a bachelor’s degree in molecular biology.
- Profile Types
- Faculty, Full-Time Faculty, and Professors & Clinical Instructors
- Areas of Interest
- Civil Procedure, Health Law, Intellectual Property & Information Law, and Patent Law
Publications
Scroll left to right to view all publications
-
Janet Freilich & Arti K. Rai, What patents on AI-derived drugs reveal 388 Science (2025)
Scholarly Commons -
Janet Freilich & Aaron S. Kesselheim, Design Patents: A Potential Threat to Drug Competition Applied Health Economics and Health Policy (2025)
Scholarly Commons -
Janet Freilich, W. Nicholson Price II & Aaron S. Kesselheim, Disappearing Data at the U.S. Federal Government New England Journal of Medicine (2025)
Scholarly Commons -
Janet Freilich & Aaron S. Kesselheim, Frequency and Nature of Generic “Design Around” of Brand-Name Patents in the United States Clinical Pharmacology & Therapeutics (2025)
Scholarly Commons -
Janet Freilich & W. Nicholson Price II, Data as Policy 66 Boston College Law Review (2025)
Scholarly Commons -
Janet Freilich & Aaron S. Kesselheim, The Patent Trial and Appeals Board: A Target for Prescription Drug Patent Reform? 332 JAMA (2024)
Scholarly Commons -
Janet Freilich, Michael J. Meurer, Mark Schankerman & Florian Schuett, A New Approach to Patent Reform 14 UC Irvine Law Review (2024)
Scholarly Commons -
Janet Freilich, Government Misinformation Platforms 172 University of Pennsylvania Law Review (2024)
Scholarly Commons -
Janet Freilich, Law as a Lamp Post Iowa Law Review (2024)
Scholarly Commons -
Janet Freilich & Sepehr Shahshahani, Measuring follow-on innovation 52 Research Policy (2023)
Scholarly Commons -
Janet Freilich & Soomi Kim, Is the Patent System Sensitive to Incorrect Information? The Review of Economics and Statistics (2023)
Scholarly Commons -
Janet Freilich, Patents' New Salience 109 Virginia Law Review (2023)
Scholarly Commons -
Janet Freilich, Paths to Downstream Innovation 55 U.C. Davis Law Review (2022)
Scholarly Commons -
Janet Freilich, Ignoring Information Quality 89 Fordham Law Review (2021)
Scholarly Commons -
Janet Freilich, The Replicability Crisis in Patent Law 95 Indiana Law Journal (2020)
Scholarly Commons -
Janet Freilich, Patent Shopping 10 UC Irvine Law Review (2020)
Scholarly Commons -
Janet Freilich, Prophetic Patents 53 U.C. Davis Law Review (2019)
Scholarly Commons -
Janet Freilich & Aaron S. Kesselheim, Data manipulation within the US Federal Government 406 The Lancet (2019)
Scholarly Commons -
Janet Freilich & Lisa Larrimore Ouellette, Science Fiction: Fictitious Experiments in Patents 364 Science (2019)
Scholarly Commons -
Janet Freilich, Patent Clutter 103 Iowa Law Review (2018)
Scholarly Commons -
Janet Freilich & Jay P. Kesan, Towards Patent Standardization 30 Harvard Journal of Law & Technology (2017)
Scholarly Commons -
Janet Freilich, The Uniformed Topograhy of Patent Scope 19 Stanford Technology Law Review (2015)
Scholarly Commons -
Janet Freilich, The Paradox of Legal Equivalents and Scientific Equivalence: Reconciling Patent Law's Doctrine of Equivalents with the FDA's Bioequivalence Requirement 66 SMU Law Review (2013)
Scholarly Commons -
Janet Freilich, Patent Infringement in the Context of Follow-On Biologics 16 Stanford Technology Law Review (2012)
Scholarly Commons -
Janet Freilich, A Nuisance Model for Patent Law 2 University of Illinois College of Law (2011)
Scholarly Commons
In the Media
Scroll left to right to view all in the media posts
-
The Journalist's Resource August 19, 2025
Government health datasets were altered without documentation, Lancet study shows
Janet Freilich is quoted.
read more -
Law360 August 14, 2025
Furtive Changes To Federal Health Data Threaten Admissibility
Janet Freilich's work is mentioned.
read more -
Medscape July 29, 2025
Judge: Trump Must Restore Missing Health Websites and Data
Janet Freilich is quoted.
read more -
Associated Press News July 24, 2025
Why are data nerds racing to save US government statistics?
Janet Freilich's work is mentioned.
read more -
IFL Science July 7, 2025
“Hidden” Changes To US Health Data Swapping “Gender” For “Sex” Spark Fears For Public Trust
Janet Freilich's work is featured.
read more -
Euro News July 4, 2025
Trump Officials ‘Secretly’ Changed Us Health Data in ‘Gender Ideology’ Crackdown, Researchers Allege
Janet Freilich's work is mentioned.
read more -
The Lancet July 3, 2025
Data Manipulation Within the US Federal Government
Janet Freilich co-authors an opinion.
read more -
Inside Precision Medicine May 30, 2025
Call for Better AI Drug Vetting Before Patent Protection
Janet Freilich's work is mentioned.
read more -
The New England Journal of Medicine March 26, 2025
Disappearing Data at the U.S. Federal Government
Janet Freilich co-authors an opinion.
read more -
Jama Network September 18, 2024
A Target for Prescription Drug Patent Reform?
Janet Freilich co-authors an opinion.
read more - View All Articles
Stories from The Record
Activities & Engagements
No upcoming activities or engagements.